A human study to evaluate safety and effectiveness of rice bran extract on postprandial triglyceride

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009893

Enrollment

Registered

2024-11-01

Start date

2024-10-25

Completion date

Unknown

Last updated

2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : After two-week run-in period, subjects who meet the criteria are randomly allocated to either the test or control group. The subjects then takes three capsules of the test food o

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Fasting blood triglyceride level < 200 mg/dL

Exclusion criteria

Exclusion criteria: - Participants with diseases(such as hyperlipidemia or uncontrolled diabetes, etc) or a medical history of such diseases - Participants who have used drugs affecting lipid or blood glucose metabolism within the past three months or are undergoing hormone replacement therapy - Participants who have regularly consumed health functional foods affecting lipid, blood glucose, or body fat metabolism within the past month - Heavy drinkers, heavy smokers, or regular intense exercisers - Participants who have participated in another clinical trial within the past month - Pregnancy or lactating women - Participants who are hypersensitive or have experienced severe allergic reactions to ingredients in the test food or control food

Design outcomes

Primary

Measure	Time frame
Blood triglyceride, apoB, cholesterol(TC, LDL-C, HDL-C, VLDL-C), glucose, insulin	—

Secondary

Measure	Time frame
Adverse events, vital signs, clinical laboratory test	—

Countries

Korea, Republic of

Contacts

Public ContactSeyeon Kim

Seoul National University of Science and Technology

sy9050@seoultech.ac.kr+82-2-974-6740

Outcome results